Search

Your search keyword '"Greulich T"' showing total 285 results

Search Constraints

Start Over You searched for: Author "Greulich T" Remove constraint Author: "Greulich T"
285 results on '"Greulich T"'

Search Results

1. Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group

2. Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic

3. Standardisation of Clinical Assessment, Management and Follow-Up of Acute Hospitalised Exacerbation of COPD: A Europe-Wide Consensus

4. The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis

5. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency

6. Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology

7. Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort

8. Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study

9. The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency

11. Alpha1-antitrypsin deficiency in Greece: Focus on rare variants

13. PI*ZQ0Attikon genotype discovery in severe alpha-1 antitrypsin deficiency

18. Alpha1-antitrypsin deficiency in Greece: Focus on rare variants

20. Α1-ANTITRYPSIN DEFICIENCY IN GREEKS: FOCUS ON RARE VARIANTS

22. The effect of COVID-19 pandemics on the comprehensive laboratory diagnostic of alpha-1 antitrypsin deficiency in Europe - report from the AATD LABNet

23. PROM and PREM preferences in COPD-patients

24. Alpha-1 Antitrypsin Deficiency Laboratory Testing-External Quality Assessment Program AATD LABNet 2019-2021

25. Α1-ANTITRYPSIN DEFICIENCY IN GREEKS: FOCUS ON RARE VARIANTS

28. S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma - Addendum 2020 : herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. und der Deutschen Atemwegsliga e.V., unter Beteiligung der Gesellschaft für Pädiatrische Pneumologie e.V. und der Österreichischen Gesellschaft für Pneumologie

29. S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma – Addendum 2020

33. COPD

38. Poster abstracts

41. Alpha-1-Antitrypsin-Mangel (AATM) – Ein Expertenstatement

44. Transcriptional analysis identifies potential biomarkers and molecular regulators in pneumonia and COPD exacerbation

45. Transcriptional Analysis identifies long non-coding RNAs as potential biomarkers in pneumonia and COPD exacerbation

49. S2k-Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma – Addendum 2020: herausgegeben von der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. und der Deutschen Atemwegsliga e.V., unter Beteiligung der Gesellschaft für Pädiatrische Pneumologie e. V. und der Österreichischen Gesellschaft für Pneumologie

Catalog

Books, media, physical & digital resources